ProCE Banner Activity

CAR T-Cell Therapy Against NHL and CLL: Current and Emerging Clinical Trial Evidence

Slideset Download
Download this slideset for expert perspectives on current best practices and emerging strategies in the use of CAR T-cell therapy for patients with lymphomas and CLL.

Released: June 23, 2020

Expiration: June 22, 2021

No longer available for credit.

Share

Faculty

Michael R. Bishop

Michael R. Bishop, MD

Professor of Medicine, Director
Section of Hematology/Oncology,
Cellular Therapy Program
University of Chicago
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Celgene

Legend Biotech USA Inc.

Faculty Disclosure

Primary Author

Michael R. Bishop, MD

Professor of Medicine, Director
Section of Hematology/Oncology,
Cellular Therapy Program
University of Chicago
Chicago, Illinois